Opening book details…
About this book
Development of 1,2,3-triazole hybrids as multi-faced anticancer agents co-targeting EGFR/mTOR pathway and tubulin depolymerization by Mennatallah A. Shaheen is a book available to read on EtoBox.
- Author
- Mennatallah A. Shaheen
- Publisher
- Elsevier Inc.
- Published
- 2025
- Language
- EN
More by Mennatallah A. Shaheen
Browse all works by Mennatallah A. Shaheen
Similar books
- Synthesis of Novel Imino-coumarin and Acrylonitrile 2-Benzazole Hybrids as Potent Anticancer Agents Targeting Tubulin — Ida Boček Pavlinac (2024)
- Coumarin-Triazole-Thiazole Hybrids: A New Avenue in Antitubercular Agents — Samin A. Shaikh (2025)
- Exploring 1,2,3-triazole-Schiff’s Base Hybrids as Innovative EGFR Inhibitors for the Treatment of Breast Cancer: In Vitro and in Silico Study — Nareman A. Nawareg (2025)
- Discovery of Novel Flavonoid Derivatives Targeting VEGFR2 and Tubulin with Potent Anticancer Efficacy — Xiang He (2025)
- Benzothiazole-triazole Hybrids: Novel Anticancer Agents Inducing Cell Cycle Arrest and Apoptosis Through Bcl-2 Inhibition in Triple-negative Breast Cancer — Aamir R. Shama (2025)
- Dual Cholinesterase Inhibition by Lactam-1,2,3-triazole Hybrids: A Click Chemistry Approach for Drug Discovery — Valeria Cavallaro (2025)